Table 1.
Baseline characteristics and oral medication regimens among the infrequent and frequent testing groups
| Infrequent testers | Frequent testers | p Value | |
|---|---|---|---|
| N | 73 | 118 | |
| Age | 63±12 | 65±11 | 0.062 |
| Gender (male) | 40 (54.7%) | 57 (48.3%) | 0.383 |
| Weight (kg) | 89.5±24.3 | 82.7±23.6 | 0.347 |
| Duration of diabetes | 15±7 | 16±9 | 0.325 |
| A1C (%, mmol/mol) | 7.3±0.9 (56±10) | 7.5±1.0 (58±69) | 0.123 |
| Diabetes complications | 45 (61.6%) | 87 (73.7%) | 0.081 |
| Metformin only | 19 (26.0%) | 16 (13.6%) | 0.033* |
| Metformin+Sulfonylurea | 18 (24.7%) | 24 (20.3%) | 0.486 |
| Metformin+Sulfonylurea+DPP-4/GLP-1 | 16 (21.9%) | 33 (28.0%) | 0.349 |
| Other | 19 (26.0%) | 36 (30.5%) | 0.445 |
| No data | 1 (1.4%) | 9 (7.6%) | n/a |
Error is expressed in 95% CIs. A ‘*’ label denotes a significant difference between groups.